Literature DB >> 2737060

Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.

P Hermanek1, I Guggenmoos-Holzmann, F P Gall.   

Abstract

In 597 patients with adenocarcinoma or mucinous adenocarcinoma of the rectum, the prognosis after radical resection for cure was investigated. Staging according to the fourth edition of the UICC TNM Classification showed a good correlation to prognosis. By multivariate analysis, various additional independent prognostic factors could be demonstrated. The individual additional prognostic factors are partly of significance in some pTNM defined stages and substages, but not in others. In order to obtain the most detailed knowledge of prognostic factors after radical resection for cure, multivariate analysis of prognostic factors in colorectal carcinoma must be performed not only in separate colonic and rectal groups, but also separately for each of the individual pTNM defined stages and substages.

Entities:  

Mesh:

Year:  1989        PMID: 2737060     DOI: 10.1007/bf02554180

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Prognostic value of additional pathological variables for long-term survival after curative resection of rectal cancer.

Authors:  Bojan Krebs; Miran Kozelj; Rajko Kavalar; Borut Gajzer; Eldar M Gadzijev
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Prognostic grouping: the next step in tumor classification.

Authors:  P Hermanek; R V Hutter; L H Sobin
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

Review 4.  Prognostic biomarkers in colorectal cancer: where do we stand?

Authors:  Xavier Sagaert
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

5.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

6.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 7.  Squamous cell cancer of the rectum.

Authors:  Tara Dyson; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

8.  Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.

Authors:  Iván González; Philip S Bauer; William C Chapman; Zahra Alipour; Rehan Rais; Jingxia Liu; Deyali Chatterjee
Journal:  Ann Diagn Pathol       Date:  2019-12-14       Impact factor: 2.090

9.  Prognostic factors and survival in a heterogeneous sample of cancer patients.

Authors:  G I Ringdal; K G Götestam; S Kaasa; S Kvinnsland; K Ringdal
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

Review 10.  Is mucinous carcinoma of the colorectum a distinct genetic entity?

Authors:  C Hanski
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.